These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 1006261)

  • 1. [Resolution of Bbeta and gamma chains from normal human fibrinogen Zürich II into 2 variants with each differing sialic acid content].
    Gati WP; Straub PW
    Schweiz Med Wochenschr; 1976 Oct; 106(40):1379. PubMed ID: 1006261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Separation of both the Bbeta- and the gamma-polypeptide chains of human fibrinogen into two main types which differ in sialic acid content.
    Gati WP; Straub PW
    J Biol Chem; 1978 Feb; 253(4):1315-21. PubMed ID: 624734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Importance of the sialic acid moiety for the heterogeneity in human fibrinogen].
    Kuyas C; Haeberli A; Straub PW
    Schweiz Med Wochenschr; 1979 Sep; 109(37):1391. PubMed ID: 482913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sialic acid dependent polypeptide chain heterogeneity of human fibrinogen demonstrated by two-dimensional electrophoresis.
    Kuyas C; Haeberli A; Straub PW
    Thromb Haemost; 1982 Feb; 47(1):19-21. PubMed ID: 7071802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal sialic acid content of the dysfibrinogenemia associated with liver disease.
    Martinez J; Palascak JE; Kwasniak D
    J Clin Invest; 1978 Feb; 61(2):535-8. PubMed ID: 621288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase of the sialic acid-rich variants of the B beta- and gamma-chains of fibrinogen Zurich II.
    Straub PW; Gati WP
    Thromb Haemost; 1979 Jun; 41(4):714-7. PubMed ID: 483245
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of sialic acid in the dysfibrinogenemia associated with liver disease: distribution of sialic acid on the constituent chains.
    Martinez J; MacDonald KA; Palascak JE
    Blood; 1983 Jun; 61(6):1196-202. PubMed ID: 6839020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fibrinogen Bern I and fibrinogen Bern II: 2 hereditary fibrinogen variants with diverse biochemical properties].
    Rupp C; Kuyas C; Haeberli A; Furlan M; von Fliedner V; Beck EA
    Schweiz Med Wochenschr; 1981 Oct; 111(41):1543-5. PubMed ID: 7313627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrospray ionisation analysis of human fibrinogen.
    Brennan SO
    Thromb Haemost; 1997 Sep; 78(3):1055-8. PubMed ID: 9308753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of variant gamma chains and sialic acid content of fibrinogen upon its interactions with ADP-stimulated human and rabbit platelets.
    Harfenist EJ; Packham MA; Mustard JF
    Blood; 1984 Dec; 64(6):1163-8. PubMed ID: 6437459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three abnormal fibrinogen variants with the same amino acid substitution (gamma 275 Arg----His): fibrinogens Bergamo II, Essen and Perugia.
    Reber P; Furlan M; Henschen A; Kaudewitz H; Barbui T; Hilgard P; Nenci GG; Berrettini M; Beck EA
    Thromb Haemost; 1986 Dec; 56(3):401-6. PubMed ID: 3563970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quality control of fibrinogen secretion in the molecular pathogenesis of congenital afibrinogenemia.
    Vu D; Di Sanza C; Caille D; de Moerloose P; Scheib H; Meda P; Neerman-Arbez M
    Hum Mol Genet; 2005 Nov; 14(21):3271-80. PubMed ID: 16195396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paris I dysfibrinogenemia: a point mutation in intron 8 results in insertion of a 15 amino acid sequence in the fibrinogen gamma-chain.
    Rosenberg JB; Newman PJ; Mosesson MW; Guillin MC; Amrani DL
    Thromb Haemost; 1993 Mar; 69(3):217-20. PubMed ID: 8470043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of intramolecular cross-linked A alpha.gamma chain heterodimers in plasma fibrinogen.
    Siebenlist KR; Mosesson MW
    Biochemistry; 1996 May; 35(18):5817-21. PubMed ID: 8639542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A subfraction of human fibrinogen with high sialic acid content and elongated gamma chains.
    Kuyas C; Haeberli A; Straub PW
    J Biol Chem; 1982 Feb; 257(3):1107-9. PubMed ID: 7056710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Residue gamma153Cys is essential for the formation of the complexes Aalphagamma and Bbetagamma, assembly intermediates for the AalphaBbetagamma complex and intact fibrinogen.
    Terasawa F; Fujita K; Okumura N
    Clin Chim Acta; 2005 Mar; 353(1-2):157-64. PubMed ID: 15698603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemical properties of plasma fibrinogens and fibrins from normal and cobalt-treated rabbits].
    Lober M; Krantz S
    Acta Biol Med Ger; 1975; 34?710():1573-88. PubMed ID: 1233845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of a monoclonal antibody, D73H, that maps to a highly conserved region on fibrinogen Bbeta chain.
    Rybarczyk BJ; Pereira M; Simpson-Haidaris PJ
    Thromb Haemost; 2000 Jul; 84(1):43-8. PubMed ID: 10928468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma and platelet fibrinogen differ in gamma chain content.
    Francis CW; Nachman RL; Marder VJ
    Thromb Haemost; 1984 Feb; 51(1):84-8. PubMed ID: 6719392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of Iranian patients allowed the identification of the first truncating mutation in the fibrinogen Bbeta-chain gene causing afibrinogenemia.
    Asselta R; Spena S; Duga S; Peyvandi F; Malcovati M; Mannucci PM; Tenchini ML
    Haematologica; 2002 Aug; 87(8):855-9. PubMed ID: 12161363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.